by
Mamisoa Andriantafika
"Doctor, is your laser the most recent one?" The question comes up often in consultation, and it is a fair one. Modern LASIK platforms offer several treatment strategies, called ablation profiles: optimized wavefront, guided wavefront, topography-guided, and, more recently, ray-tracing guided. Every manufacturer promotes its own. So which one should you choose?
A debate between two leading names in refractive surgery, held at the ASCRS 2026 congress in the United States and reported by the ESCRS journal EuroTimes, offers a refreshing answer: all of these profiles deliver excellent results, and the most decisive factor is not the machine. It is the surgeon's experience. This article explains what sets these refractive surgery techniques apart, and what it means for you.
The principle behind LASIK never changes: an excimer laser reshapes the cornea to correct myopia, hyperopia or astigmatism. What varies is how the target shape is calculated. The optimized wavefront profile (WFO) is today's standard: it corrects your glasses prescription while preserving the cornea's natural shape, based on population averages. The wavefront-guided profile (WFG) goes further: it measures the optical imperfections specific to your eye, called aberrations, and factors them into the treatment.
The topography-guided profile (TPG) relies on a detailed map of your cornea's surface relief. Finally, the newest arrival, the ray-tracing guided profile (RTG), builds a personalized 3D model of the entire eye and simulates the path light takes through it. Its platform only received CE marking in 2019, and FDA approval in the United States in 2025.
Four calculation strategies for the same goal: restoring sharp vision without glasses.
All of these profiles are applied by the same type of excimer laser. The difference happens upstream, in the preoperative work-up and the treatment calculation: that is where the surgeon chooses the strategy suited to each eye.
Differences between profiles do exist, but they are subtle: all of them can achieve 20/20.
The scientific literature is abundant. A meta-analysis of the earliest studies comparing wavefront-guided and wavefront-optimized treatments concluded that outcomes were comparable. More recent randomized trials, notably those from Professor Manche's team at Stanford, where each patient received a different technique in each eye, show a slight advantage for wavefront-guided treatment: more eyes reaching acuities better than 20/20, better contrast vision and more gains in best corrected acuity.
For the topography-guided profile, the studies are contradictory: some find it equivalent to the standard, and one recent trial even finds it slightly inferior. What matters most: on the criterion that counts for the patient, seeing clearly without glasses, all modern profiles deliver excellent results. The gaps play out in nuances of visual quality, not in the success or failure of the operation.
| Ablation profile | What it relies on | Key takeaway |
|---|---|---|
| Optimized wavefront (WFO) | Glasses prescription + population averages | Today's standard, simple and proven |
| Wavefront-guided (WFG) | Optical aberrations measured on your eye | Slight advantage in recent randomized trials |
| Topography-guided (TPG) | Map of your cornea's surface relief | Conflicting study results; useful on irregular corneas |
| Ray-tracing guided (RTG) | Personalized 3D model of the whole eye | The most recent; promising, comparative studies ongoing |
Ray tracing deserves a closer look, because it represents the next generation of personalization. Where wavefront-guided treatment addresses aberrations measured against a theoretical eye model, ray tracing builds a 3D model of your entire eye from aberrometry and corneal tomography measurements. It even factors in the cornea's expected biomechanical changes and epithelial remodeling, then simulates several treatment plans to select the most optimal one.
Its main proponent, Professor Kanellopoulos, describes it as a "wavefront-guided plus": its interest lies not in achieving 20/20, which every technique already reaches, but in the quality of vision beyond that, with a sharper retinal image. It could also make future lens surgery easier by leaving the cornea more regular relative to the visual axis. But let's stay measured: the technique is young, and direct comparative studies against wavefront-guided treatment are still ongoing.
Ray tracing does not just aim for 20/20: it aims for the quality of the image that forms on the retina.
This sophistication comes at a price: the more personalized a treatment is, the more it depends on the quality of the measurements feeding it. A rigorous preoperative work-up becomes even more decisive.
No profile, however sophisticated, accounts for the crystalline lens and its accommodation.
The surgeons in the debate acknowledge it themselves: there is an "elephant in the room." None of the personalized treatments accounts for the crystalline lens, the eye's natural lens located behind the pupil. In younger patients, though, the lens accommodates continuously to focus, and this accommodation changes the aberrations that get measured. Measurements taken at the wrong moment can therefore skew a treatment meant to be "tailor-made."
A safeguard exists: taking the measurements under cycloplegia, that is, using drops that temporarily put accommodation at rest, following a precise protocol. But this safeguard illustrates the key point rather well. Mastering these subtleties, knowing when a measurement is reliable and when it is not, is part of the surgeon's learning curve. Technology does not replace this judgment. It demands it.
At the end of the debate, the two experts converge on a conclusion that may surprise attendees of a technology-focused congress. Professor Kanellopoulos sums it up: a surgeon who does not deeply master the scientific principles behind personalized treatments will still achieve excellent results with the standard optimized wavefront profile. One who is comfortable with the more complex planning of guided profiles will get the most out of them. Either way, what makes the difference is mastery, not the label of the technique.
His formula is worth quoting: "I still believe that the best customisation tool for LASIK is the experienced refractive surgeon." Setting the right indication, ruling out at-risk eyes, choosing the strategy suited to each cornea, interpreting measurements that can sometimes be misleading: it is this work, invisible to the patient, that shapes the outcome far more than the name of the ablation profile.
"I still believe that the best customisation tool for LASIK is the experienced refractive surgeon."
This is also good news: the outcome of your surgery does not depend on a race for the newest machine, but on a rigorous work-up and a team that has mastered its platform, such as our dedicated laser suite.
What should you take away as a patient? First, that every modern LASIK technique, well indicated and well executed, delivers excellent results: differences between ablation profiles are measured in nuances of visual quality, not in success or failure. Second, that the marketing argument of the "newest laser" should not guide your choice. Choose a center instead for the quality of its preoperative work-up, the transparency of its indications, including when the answer is not to operate, and the experience of its team. You can also assess your eligibility for refractive surgery, and take a closer look at how wavefront-guided LASIK compares with other techniques: LASIK is a mature technique, whose true personalization begins in the consultation room.
